BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12648587)

  • 21. Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction.
    Cerisano G; Pucci PD; Sulla A; Tommasi M; Raspanti S; Santoro GM; Antoniucci D
    Am J Cardiol; 2007 Mar; 99(5):651-6. PubMed ID: 17317366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
    Simojoki M; Santala M; Risteli J; Risteli L; Kauppila A
    Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects.
    Tähtelä R; Turpeinen M; Sorva R; Karonen SL
    Clin Biochem; 1997 Feb; 30(1):35-40. PubMed ID: 9056107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
    Elomaa I; Virkkunen P; Risteli L; Risteli J
    Br J Cancer; 1992 Aug; 66(2):337-41. PubMed ID: 1503907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
    Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum carboxy-terminal cross-linked telopeptide of type I collagen reflects bone metastasis in hepatocellular carcinoma.
    Ueno T; Hashimoto O; Sugawara H; Ogata R; Kusaba N; Torimura T; Sata M; Tanikawa K
    Int J Oncol; 1998 Aug; 13(2):297-303. PubMed ID: 9664125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
    Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
    Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated serum ICTP concentrations reflect poor prognosis in patients with ovarian carcinoma.
    Santala M; Risteli L; Puistola U; Risteli J; Kauppila A
    Ann Med; 1995 Feb; 27(1):57-61. PubMed ID: 7742000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement.
    Scheja A; Wildt M; Wollheim FA; Akesson A; Saxne T
    Rheumatology (Oxford); 2000 Oct; 39(10):1110-3. PubMed ID: 11035131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulated type I collagen turnover in patients with giant cell tumor of bone.
    Nakashima H; Sugiura H; Nishida Y; Yamada Y; Tabata I; Ishiguro N
    Calcif Tissue Int; 2003 Jul; 73(1):5-8. PubMed ID: 14506947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapy.
    Suvanto-Luukkonen E; Risteli L; Sundström H; Penttinen J; Kauppila A; Risteli J
    Clin Chim Acta; 1997 Oct; 266(2):105-16. PubMed ID: 9437539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer.
    Santala M; Risteli J; Risteli L; Puistola U; Kacinski BM; Stanley ER; Kauppila A
    Br J Cancer; 1998 Jun; 77(11):1825-31. PubMed ID: 9667653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annual serum PICP and ICTP and antler growth in female reindeer (Rangifer tarandus tarandus).
    Vierimaa H; Sassi ML; Eloranta E; Rahiala M; Timisjärvi J; Saarela S; Risteli J
    Comp Biochem Physiol B Biochem Mol Biol; 1999 Jan; 122(1):111-7. PubMed ID: 10327601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer.
    Jukkola A; Bloigu R; Holli K; Joensuu H; Valavaara R; Risteli J; Blanco G
    Anticancer Res; 2001; 21(4B):2873-6. PubMed ID: 11712779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
    Noguchi M; Noda S
    J Urol; 2001 Sep; 166(3):1106-10. PubMed ID: 11490307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.
    Kjeldsen J; Schaffalitzky de Muckadell OB; Junker P
    Gut; 1995 Dec; 37(6):805-10. PubMed ID: 8537052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum markers of type I collagen synthesis and degradation in amyotrophic lateral sclerosis.
    Ono S; Imai T; Shimizu N; Nakayama M; Yamano T; Tsumura M
    Eur Neurol; 2000; 44(1):49-56. PubMed ID: 10894996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.
    Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Szymańska A; Nahaczewska W
    Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.
    Kylmälä T; Tammela TL; Risteli L; Risteli J; Kontturi M; Elomaa I
    Br J Cancer; 1995 May; 71(5):1061-4. PubMed ID: 7734300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.